Cargando…

Current landscape and future perspectives in preclinical MR and PET imaging of brain metastasis

Brain metastasis (BM) is a major cause of cancer patient morbidity. Clinical magnetic resonance imaging (MRI) and positron emission tomography (PET) represent important resources to assess tumor progression and treatment responses. In preclinical research, anatomical MRI and to some extent functiona...

Descripción completa

Detalles Bibliográficos
Autores principales:	Aasen, Synnøve Nymark, Espedal, Heidi, Keunen, Olivier, Adamsen, Tom Christian Holm, Bjerkvig, Rolf, Thorsen, Frits
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Reviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8704384/ https://www.ncbi.nlm.nih.gov/pubmed/34988446 http://dx.doi.org/10.1093/noajnl/vdab151

Ejemplares similares

THER-11. PEPTIDE-MEDIATED PERMEABILIZATION OF THE BLOOD-BRAIN BARRIER IMPROVES DRUG DELIVERY TO BRAIN METASTASIS
por: Aasen, Synnøve Nymark, et al.
Publicado: (2019)

Effective Treatment of Metastatic Melanoma by Combining MAPK and PI3K Signaling Pathway Inhibitors
por: Nymark Aasen, Synnøve, et al.
Publicado: (2019)

Cabozantinib Is Effective in Melanoma Brain Metastasis Cell Lines and Affects Key Signaling Pathways
por: Mannsåker, Trond Are, et al.
Publicado: (2021)

CCT196969 effectively inhibits growth and survival of melanoma brain metastasis cells
por: Reigstad, Agathe, et al.
Publicado: (2022)

Lack of functional normalisation of tumour vessels following anti-angiogenic therapy in glioblastoma
por: Obad, Nina, et al.
Publicado: (2017)

A Novel Nanoprobe for Multimodal Imaging Is Effectively Incorporated into Human Melanoma Metastatic Cell Lines
por: Aasen, Synnøve Nymark, et al.
Publicado: (2015)

Inhibition of mitochondrial respiration prevents BRAF-mutant melanoma brain metastasis
por: Sundstrøm, Terje, et al.
Publicado: (2019)

BSCI-12. Inhibition of melanoma brain metastasis by targeting miR-146a
por: Wang, Jiwei, et al.
Publicado: (2021)

Engraftment of Human Glioblastoma Cells in Immunocompetent Rats through Acquired Immunosuppression
por: Huszthy, Peter C., et al.
Publicado: (2015)

Correction: Engraftment of Human Glioblastoma Cells in Immunocompetent Rats through Acquired Immunosuppression
por: Huszthy, Peter C., et al.
Publicado: (2015)

In Vitro Treatment of Melanoma Brain Metastasis by Simultaneously Targeting the MAPK and PI3K Signaling Pathways
por: Daphu, Inderjit, et al.
Publicado: (2014)

Evaluation of PET performance and MR compatibility of a preclinical PET/MR insert with digital silicon photomultiplier technology
por: Hallen, Patrick, et al.
Publicado: (2015)

MR-compatibility study of a preclinical digital PET/MRI insert
por: Wehner, Jakob, et al.
Publicado: (2014)

Imaging of Preclinical Endometrial Cancer Models for Monitoring Tumor Progression and Response to Targeted Therapy
por: Espedal, Heidi, et al.
Publicado: (2019)

Use of a clinical PET/MR scanner for preclinical research with first results
por: Chary, Karthik, et al.
Publicado: (2014)

Bevacizumab treatment induces metabolic adaptation toward anaerobic metabolism in glioblastomas
por: Fack, Fred, et al.
Publicado: (2014)

Diagnostic Value of Delayed PET/MR in Liver Metastasis in Comparison With PET/CT
por: Zhou, Nina, et al.
Publicado: (2021)

Altered metabolic landscape in IDH‐mutant gliomas affects phospholipid, energy, and oxidative stress pathways
por: Fack, Fred, et al.
Publicado: (2017)

Editorial: The Role of the Immune Response in Brain Metastasis
por: Sibson, Nicola R., et al.
Publicado: (2022)

A Practical Quality Assurance Procedure for Data Acquisitions in Preclinical Simultaneous PET/MR Systems
por: Courteau, Alan, et al.
Publicado: (2022)

Transmembrane protein CD9 is glioblastoma biomarker, relevant for maintenance of glioblastoma stem cells
por: Podergajs, Neža, et al.
Publicado: (2015)

In vivo models of primary brain tumors: pitfalls and perspectives
por: Huszthy, Peter C., et al.
Publicado: (2012)

The SAFIR project: an innovative high rate preclinical PET/MR detector towards dynamic multimodal imaging
por: Becker, Robert, et al.
Publicado: (2015)

The Conundrum of PET/MR
por: Kannivelu, Anbalagan, et al.
Publicado: (2012)

Feasibility and utility of MRI and dynamic (18)F-FDG-PET in an orthotopic organoid-based patient-derived mouse model of endometrial cancer
por: Espedal, Heidi, et al.
Publicado: (2021)

PET/MR imaging: current status and future direction
por: Schlemmer, Heinz-Peter
Publicado: (2015)

Hybrid imaging with PET/CT and PET/MR
por: Kjaer, Andreas
Publicado: (2014)

Do carotid MR surface coils affect PET quantification in PET/MR imaging?
por: Willemink, Martin J, et al.
Publicado: (2015)

Image artifacts from MR-based attenuation correction in dedicated PET/MR breast coil for PET/MR mammography
por: Cho, Ihnho, et al.
Publicado: (2015)

Preclinical and first-in-human-brain-cancer applications of [(18)F]poly (ADP-ribose) polymerase inhibitor PET/MR
por: Young, Robert J, et al.
Publicado: (2020)

Preclinical PET and MR Evaluation of (89)Zr- and (68)Ga-Labeled Nanodiamonds in Mice over Different Time Scales
por: Winter, Gordon, et al.
Publicado: (2022)

PET/MR: improvement of the UTE μ-maps using modified MLAA
por: Benoit, Didier, et al.
Publicado: (2015)

Trifluoperazine, a novel autophagy inhibitor, increases radiosensitivity in glioblastoma by impairing homologous recombination
por: Zhang, Xin, et al.
Publicado: (2017)

PMEPA1 isoform a drives progression of glioblastoma by promoting protein degradation of the Hippo pathway kinase LATS1
por: Ji, Jianxiong, et al.
Publicado: (2019)

MR-Based PET Motion Correction Procedure for Simultaneous MR-PET Neuroimaging of Human Brain
por: Ullisch, Marcus Görge, et al.
Publicado: (2012)

PET-MR and SPECT-MR multimodality probes: Development and challenges
por: Yang, Chang-Tong, et al.
Publicado: (2018)

PET/MR in children. Initial clinical experience in paediatric oncology using an integrated PET/MR scanner
por: Hirsch, Franz Wolfgang, et al.
Publicado: (2013)

Variation in urinary excretion of FDG, yet another uncertainty in quantitative PET
por: Bach-Gansmo, Tore, et al.
Publicado: (2012)

Radiation treatment monitoring using multimodal functional imaging: PET/CT ((18)F-Fluoromisonidazole & (18)F-Fluorocholine) and DCE-US
por: Arteaga-Marrero, Natalia, et al.
Publicado: (2015)

Respiratory motion correction of PET using MR-constrained PET-PET registration
por: Balfour, Daniel R., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_2dj60d2b0avjep074ibpairnes